Copyright
©The Author(s) 2022.
World J Clin Cases. Jan 14, 2022; 10(2): 426-436
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.426
Published online Jan 14, 2022. doi: 10.12998/wjcc.v10.i2.426
Indicator | Group | Before the medication | After the medication |
Lymphocyte | Control group | 1.35 ± 0.39 | 1.58 ± 0.44 |
Corticosteroid group | 1.34 ± 0.54 | 1.61 ± 0.62 | |
ESR | Control group | 25.22 ± 18.41 | 15.41 ± 9.67 |
Corticosteroid group | 25.71 ± 14.74 | 13.79 ± 8.24 | |
LDH | Control group | 171.66 ± 50.70 | 136.06 ± 36.80 |
Corticosteroid group | 226.13 ± 82.36 | 187.05 ± 68.53 | |
SF | Control group | 344.69 ± 209.42 | 202.22 ± 109.76 |
Corticosteroid group | 428.28 ± 249.29 | 255.19 ± 105.59 |
- Citation: Lin L, Xue D, Chen JH, Wei QY, Huang ZH. Methylprednisolone accelerate chest computed tomography absorption in COVID-19: A three-centered retrospective case control study from China. World J Clin Cases 2022; 10(2): 426-436
- URL: https://www.wjgnet.com/2307-8960/full/v10/i2/426.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i2.426